These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32937783)

  • 1. The Pathopharmacological Interplay between Vanadium and Iron in Parkinson's Disease Models.
    Ohiomokhare S; Olaolorun F; Ladagu A; Olopade F; Howes MR; Okello E; Olopade J; Chazot PL
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ginseng protein protects against mitochondrial dysfunction and neurodegeneration by inducing mitochondrial unfolded protein response in Drosophila melanogaster PINK1 model of Parkinson's disease.
    Liu M; Yu S; Wang J; Qiao J; Liu Y; Wang S; Zhao Y
    J Ethnopharmacol; 2020 Jan; 247():112213. PubMed ID: 31562951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological manipulation of ataxia-telangiectasia kinase activity as a treatment for Parkinson's disease.
    Edwin Shackelford R; Manuszak RP; Heard SC; Link CJ; Wang S
    Med Hypotheses; 2005; 64(4):736-41. PubMed ID: 15694690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators.
    Weinreb O; Mandel S; Youdim MBH; Amit T
    Free Radic Biol Med; 2013 Sep; 62():52-64. PubMed ID: 23376471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification.
    Bjørklund G; Hofer T; Nurchi VM; Aaseth J
    J Inorg Biochem; 2019 Oct; 199():110717. PubMed ID: 31369907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.
    Zuo L; Motherwell MS
    Gene; 2013 Dec; 532(1):18-23. PubMed ID: 23954870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transferrin1 modulates rotenone-induced Parkinson's disease through affecting iron homeostasis in Drosophila melanogaster.
    Xue J; Wang HL; Xiao G
    Biochem Biophys Res Commun; 2020 Oct; 531(3):305-311. PubMed ID: 32800558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Chelation Nanoparticles with Delayed Saturation as an Effective Therapy for Parkinson Disease.
    Wang N; Jin X; Guo D; Tong G; Zhu X
    Biomacromolecules; 2017 Feb; 18(2):461-474. PubMed ID: 27989126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.
    Devos D; Cabantchik ZI; Moreau C; Danel V; Mahoney-Sanchez L; Bouchaoui H; Gouel F; Rolland AS; Duce JA; Devedjian JC;
    J Neural Transm (Vienna); 2020 Feb; 127(2):189-203. PubMed ID: 31912279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling.
    Yang Y; Gehrke S; Haque ME; Imai Y; Kosek J; Yang L; Beal MF; Nishimura I; Wakamatsu K; Ito S; Takahashi R; Lu B
    Proc Natl Acad Sci U S A; 2005 Sep; 102(38):13670-5. PubMed ID: 16155123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parkinson's disease and iron.
    Mochizuki H; Choong CJ; Baba K
    J Neural Transm (Vienna); 2020 Feb; 127(2):181-187. PubMed ID: 32025811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ironing iron out in Parkinson's disease and other neurodegenerative diseases with iron chelators: a lesson from 6-hydroxydopamine and iron chelators, desferal and VK-28.
    Youdim MB; Stephenson G; Ben Shachar D
    Ann N Y Acad Sci; 2004 Mar; 1012():306-25. PubMed ID: 15105275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of oxidative stress mechanisms and the effects of phytotherapic extracts on Parkinson's disease
    Baroli B; Loi E; Solari P; Kasture A; Moi L; Muroni P; Kasture S; Setzu MD; Liscia A; Zavattari P
    FASEB J; 2019 Oct; 33(10):11028-11034. PubMed ID: 31291788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons.
    Kooncumchoo P; Sharma S; Porter J; Govitrapong P; Ebadi M
    J Mol Neurosci; 2006; 28(2):125-41. PubMed ID: 16679553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?
    Kaur D; Andersen JK
    Aging Cell; 2002 Oct; 1(1):17-21. PubMed ID: 12882349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine and Curcumin Loaded Nanocarriers Protect Against Rotenone-Induced Neurotoxicity.
    Mursaleen L; Somavarapu S; Zariwala MG
    J Parkinsons Dis; 2020; 10(1):99-111. PubMed ID: 31868679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting chelatable iron as a therapeutic modality in Parkinson's disease.
    Devos D; Moreau C; Devedjian JC; Kluza J; Petrault M; Laloux C; Jonneaux A; Ryckewaert G; Garçon G; Rouaix N; Duhamel A; Jissendi P; Dujardin K; Auger F; Ravasi L; Hopes L; Grolez G; Firdaus W; Sablonnière B; Strubi-Vuillaume I; Zahr N; Destée A; Corvol JC; Pöltl D; Leist M; Rose C; Defebvre L; Marchetti P; Cabantchik ZI; Bordet R
    Antioxid Redox Signal; 2014 Jul; 21(2):195-210. PubMed ID: 24251381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevating bioavailable iron levels in mitochondria suppresses the defective phenotypes caused by PINK1 loss-of-function in Drosophila melanogaster.
    Wan Z; Xu J; Huang Y; Zhai Y; Ma Z; Zhou B; Cao Z
    Biochem Biophys Res Commun; 2020 Nov; 532(2):285-291. PubMed ID: 32873392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of Rapid Influx of Extracellular Zn
    Tamano H; Morioka H; Nishio R; Takeuchi A; Takeda A
    Mol Neurobiol; 2019 Jun; 56(6):4539-4548. PubMed ID: 30341553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. l-3,4-dihydroxyphenylalanine (l-DOPA) modulates brain iron, dopaminergic neurodegeneration and motor dysfunction in iron overload and mutant alpha-synuclein mouse models of Parkinson's disease.
    Billings JL; Gordon SL; Rawling T; Doble PA; Bush AI; Adlard PA; Finkelstein DI; Hare DJ
    J Neurochem; 2019 Jul; 150(1):88-106. PubMed ID: 30716176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.